Kevin Caliendo
Stock Analyst at UBS
(3.99)
# 1,772
Out of 4,609 analysts
394
Total ratings
58.1%
Success rate
5.7%
Average return
Main Sectors:
Stocks Rated by Kevin Caliendo
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| COR Cencora | Maintained: Buy | $412 → $430 | $315.06 | +36.48% | 27 | Aug 6, 2026 | |
| CVS CVS Health | Maintained: Buy | $122 → $126 | $96.65 | +30.37% | 35 | Aug 6, 2026 | |
| MCK McKesson | Maintained: Buy | $1,050 → $1,080 | $844.65 | +27.86% | 33 | Aug 6, 2026 | |
| AHCO AdaptHealth | Maintained: Buy | $14 → $10 | $6.38 | +56.74% | 18 | Aug 6, 2026 | |
| HSIC Henry Schein | Maintained: Hold | $89 → $94 | $89.70 | +4.79% | 11 | Aug 5, 2026 | |
| LH Labcorp Holdings | Maintained: Buy | $320 → $361 | $314.35 | +14.84% | 21 | Jul 31, 2026 | |
| WAY Waystar Holding | Maintained: Buy | $37 → $33 | $23.31 | +41.57% | 3 | Jul 30, 2026 | |
| MDLN Medline | Maintained: Buy | $57 → $50 | $35.25 | +41.84% | 3 | Jul 29, 2026 | |
| DGX Quest Diagnostics | Maintained: Hold | $220 → $232 | $236.49 | -1.90% | 19 | Jul 24, 2026 | |
| ALGN Align Technology | Maintained: Hold | $186 → $189 | $171.94 | +9.92% | 26 | Jul 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $260 → $274 | $235.28 | +16.46% | 23 | Jul 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 | $6.74 | -10.98% | 16 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 → $4.5 | $3.01 | +49.50% | 19 | May 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $5 | $3.72 | +34.59% | 8 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $12 → $13 | $10.86 | +19.71% | 15 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $18 → $17 | $13.64 | +24.63% | 20 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $82 → $78 | $83.30 | -6.36% | 4 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $4 → $2 | $3.69 | -45.80% | 8 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $390 → $375 | $271.20 | +38.27% | 11 | Feb 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $22 → $25 | $27.85 | -10.23% | 5 | Feb 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $17 → $18 | $13.58 | +32.60% | 13 | Oct 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $374 → $180 | $194.05 | n/a | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $9 | $12.76 | n/a | 9 | May 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $250 → $285 | $356.52 | n/a | 12 | Feb 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $72 → $79 | $64.15 | n/a | 2 | Dec 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $520 → $640 | $405.10 | n/a | 10 | Oct 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $595 → $610 | $388.08 | n/a | 3 | Oct 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $180 → $175 | $256.32 | n/a | 4 | Oct 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $15.48 | n/a | 1 | Mar 9, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $11 → $10 | $34.56 | n/a | 5 | Feb 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $8 | $4.95 | n/a | 2 | Mar 3, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $131.92 | n/a | 1 | Jan 30, 2018 |
Cencora
Aug 6, 2026
Maintained: Buy
Price Target: $412 → $430
Current: $315.06
Upside: +36.48%
CVS Health
Aug 6, 2026
Maintained: Buy
Price Target: $122 → $126
Current: $96.65
Upside: +30.37%
McKesson
Aug 6, 2026
Maintained: Buy
Price Target: $1,050 → $1,080
Current: $844.65
Upside: +27.86%
AdaptHealth
Aug 6, 2026
Maintained: Buy
Price Target: $14 → $10
Current: $6.38
Upside: +56.74%
Henry Schein
Aug 5, 2026
Maintained: Hold
Price Target: $89 → $94
Current: $89.70
Upside: +4.79%
Labcorp Holdings
Jul 31, 2026
Maintained: Buy
Price Target: $320 → $361
Current: $314.35
Upside: +14.84%
Waystar Holding
Jul 30, 2026
Maintained: Buy
Price Target: $37 → $33
Current: $23.31
Upside: +41.57%
Medline
Jul 29, 2026
Maintained: Buy
Price Target: $57 → $50
Current: $35.25
Upside: +41.84%
Quest Diagnostics
Jul 24, 2026
Maintained: Hold
Price Target: $220 → $232
Current: $236.49
Upside: -1.90%
Align Technology
Jul 23, 2026
Maintained: Hold
Price Target: $186 → $189
Current: $171.94
Upside: +9.92%
Jul 20, 2026
Rated: Buy
Price Target: $260 → $274
Current: $235.28
Upside: +16.46%
May 15, 2026
Maintained: Hold
Price Target: $6
Current: $6.74
Upside: -10.98%
May 12, 2026
Rated: Hold
Price Target: $3 → $4.5
Current: $3.01
Upside: +49.50%
May 8, 2026
Reiterated: Buy
Price Target: $5
Current: $3.72
Upside: +34.59%
May 8, 2026
Maintained: Buy
Price Target: $12 → $13
Current: $10.86
Upside: +19.71%
May 7, 2026
Maintained: Buy
Price Target: $18 → $17
Current: $13.64
Upside: +24.63%
May 6, 2026
Maintained: Hold
Price Target: $82 → $78
Current: $83.30
Upside: -6.36%
Feb 27, 2026
Maintained: Hold
Price Target: $4 → $2
Current: $3.69
Upside: -45.80%
Feb 9, 2026
Maintained: Buy
Price Target: $390 → $375
Current: $271.20
Upside: +38.27%
Feb 3, 2026
Maintained: Hold
Price Target: $22 → $25
Current: $27.85
Upside: -10.23%
Oct 31, 2025
Maintained: Hold
Price Target: $17 → $18
Current: $13.58
Upside: +32.60%
Jul 25, 2025
Maintained: Hold
Price Target: $374 → $180
Current: $194.05
Upside: n/a
May 8, 2025
Maintained: Hold
Price Target: $12 → $9
Current: $12.76
Upside: n/a
Feb 24, 2025
Maintained: Hold
Price Target: $250 → $285
Current: $356.52
Upside: n/a
Dec 21, 2023
Maintained: Hold
Price Target: $72 → $79
Current: $64.15
Upside: n/a
Oct 16, 2023
Upgraded: Buy
Price Target: $520 → $640
Current: $405.10
Upside: n/a
Oct 24, 2022
Maintained: Buy
Price Target: $595 → $610
Current: $388.08
Upside: n/a
Oct 3, 2022
Maintained: Hold
Price Target: $180 → $175
Current: $256.32
Upside: n/a
Mar 9, 2022
Upgraded: Buy
Price Target: n/a
Current: $15.48
Upside: n/a
Feb 10, 2022
Maintained: Hold
Price Target: $11 → $10
Current: $34.56
Upside: n/a
Mar 3, 2020
Maintained: Hold
Price Target: $12 → $8
Current: $4.95
Upside: n/a
Jan 30, 2018
Upgraded: Buy
Price Target: n/a
Current: $131.92
Upside: n/a